Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I trial of PBI-4547 for non-alcoholic steatohepatitis

Trial Profile

Phase I trial of PBI-4547 for non-alcoholic steatohepatitis

Planning
Phase of Trial: Phase I

Latest Information Update: 20 Feb 2018

At a glance

  • Drugs PBI 4547 (Primary)
  • Indications Non-alcoholic steatohepatitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Feb 2018 According to a ProMetic Life Sciences media release, company plans to initiate this trial in Q2 2018.
    • 12 Jun 2017 According to a ProMetic Life Sciences media release, this trial is expected to initiate in the fourth quarter of 2017.
    • 23 May 2017 According to a ProMetic Life Sciences media release, this trial is expected to initiate in the first quarter of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top